ROCO
4971
Market cap482mUSD
Jul 09, Last price
421.00TWD
1D
-3.77%
1Q
-34.93%
Jan 2017
413.41%
IPO
466.70%
Name
IntelliEPI Inc (Cayman)
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IntelliEPI Inc. (Cayman), operating through its subsidiaries, specializes as a manufacturer and supplier of advanced compound semiconductor epitaxy wafers. These specialized components are vital for cutting-edge technologies in wireless communication, data transmission, and national defense applications. The company boasts a global presence, serving key markets including the United States, Germany, China, Japan, and Korea. A cornerstone of its operation is the use of proprietary Molecular Beam Epitaxy (MBE) systems, which integrate real-time in situ growth monitoring technology. This sophisticated manufacturing process enables the creation of high-quality epi-wafers built on Gallium Arsenide (GaAs) and Indium Phosphide (InP) substrates. IntelliEPI's extensive product portfolio encompasses: GaAs-based solutions: Such as pseudo-morphic high electron mobility transistors (pHEMTs) and MHEMT products. InP-based offerings: Including hetero-junction bipolar transistors (HBTs), HEMTs, RTT, and RTD components. Antimony (Sb)-based products: Featuring Type II SLS photodetectors, GaAsSb-based InP HBTs, and epi-ready Gallium Antimonide (GaSb) substrates. Mismatched epitaxy products: Like III-V on Silicon (Si), III-V on Germanium (Ge), and high indium content Indium Gallium Arsenide (InGaAs) on Silicon. Optoelectronic devices: A wide array including avalanche photodiodes (APDs), various types of lasers (such as high-speed high-frequency surface-emitting lasers and quantum cascade lasers), optical receivers, quantum well-infrared photodetectors (QWIPs), modulators, and general infrared light detectors. Established in 1999, IntelliEPI maintains its corporate headquarters in Richardson, Texas.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||